Table 2. Dysregulation of GPRC5A in different diseases.
| Disease | Level Cancer vs. Normal | Methods | Reference |
|---|---|---|---|
| Oral Squamous Cell Carcinoma |  |
IHC | [10] |
| Non-Small Cell Lung Carcinoma | |
Microarray; qRT-PCR; | [78, 85] |
| Chronic Obstructive Pulmonary Disease | |
Microarray; qRT-PCR; | [85] |
| Breast Carcinoma# | |
NGS; RT-PCR | [13] |
| Primary Myelodysplastic Syndeome | |
Microarray | [86] |
| Hepatocellular Carcinoma | N/A(d) | Microarray | [8] |
| Hepatocellular Carcinoma | |
qRT-PCR | [84] |
| Colorectal Adenocarcinoma |  |
LC-MS/MS | [12] |
| Breast Carcinoma (Primary) | |
Microarray | [81] |
| Breast Carcinoma (Invasive) | |
CPA; IHC | [82] |
| Colorectal Adenocarcinoma | |
LC-MS/MS;IHC | [5] |
| Atherosclerosis(a) | |
Microarray | [9] |
| Gastric Carcinoma | |
Microarray; qRT-PCR; | [7] |
| Breast Carcinoma | |
qRT-PCR | [80] |
| Intreheptic Cholangiocarcinoma | |
Microarray; qRT-PCR | [11] |
| Pancreatic Ductal Adenocarcinoma(b) | |
Microarray | [27] |
| Breast Carcinoma(c) | |
Microarray; qRT-PCR | [27] |
| Hepatocellular Carcinoma | |
qRT-PCR; WB; IHC | [83] |
#
BRCA1 5382insC mutation carrier vs. BRCA1 wild-type patients.
(a)
The SMC cell line is analyzed in this study.
(b)
Pancreatic cell lines are analyzed in this study.
(c)
Breast cell lines are analyzed in this study.
(d)
GPRC5A expression level is compared within patients before treatment and after treatment. GPRC5A is up-regulated after treatment.